Habibizad Nazila

CIK 00019139611 companySOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001913961

Recent Transactions

50 trades

Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−26,454→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−548→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−23,424→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−3,724→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−1,746→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−8,353→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−5,995→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−938→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−2,750→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−6,300→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−2,329→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−7,917→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−4,448→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Common Stock
2022-10-05−39,680→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−15,460→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−28,628→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−5,957→ 0 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-01−1,375→ 2,750 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-10-01+1,375→ 39,498 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-10-01+182→ 39,680 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-01−182→ 548 total
Gift
Global Blood Therapeutics, Inc.
Common Stock
2022-09-29−3,500→ 38,123 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-09-27$48.44/sh+1,027→ 41,540 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-09-27$59.60/sh+2,043→ 40,513 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-09-27−23,597→ 0 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-09-27−2,043→ 5,957 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-09-27−83→ 7,917 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-09-27$46.99/sh+83→ 41,623 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-09-27−3,005→ 5,995 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-09-27$12.95/sh+23,597→ 35,465 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-09-27$29.75/sh+3,005→ 38,470 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-09-27−1,027→ 4,448 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-09-01−2,208→ 15,460 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-09-01+2,208→ 13,210 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2022-09-01$68.15/sh−1,342→ 11,868 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-09-01+1,670→ 11,002 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-09-01−1,670→ 8,353 total
Award
Global Blood Therapeutics, Inc.
Common Stock
2022-08-31$25.37/sh+414→ 9,332 total
Sale
Global Blood Therapeutics, Inc.
Common Stock
2022-08-18$67.19/sh−4,678→ 8,918 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2022-08-01$32.40/sh−526→ 13,596 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-08-01−937→ 938 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-08-01+1,518→ 14,122 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-08-01−581→ 1,746 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-04-01−1,375→ 4,125 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2022-04-01$35.91/sh−540→ 30,036 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-04-01−183→ 730 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-04-01+1,558→ 30,576 total
Award
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-03-01+17,668→ 17,668 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-03-01+1,671→ 29,631 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2022-03-01$29.87/sh−613→ 29,018 total

Companies

Global Blood Therapeutics, Inc.
See Remarks

Recent Filings

Address

C/O GLOBAL BLOOD THERAPEUTICS, INC. 181 OYSTER POINT BLVD.

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov